Lynch, M A <br/><br/>
Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.  [electronic resource] 

 -  Gene expression  2001 
 - 157-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1052-2166 
<br/><br/><label>Standard No.: </label>10.3727/000000001783992560  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blotting, Western<br/>Breast Neoplasms--metabolism<br/>Cell Division--drug effects<br/>DNA Mutational Analysis<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm<br/>Female<br/>G1 Phase--drug effects<br/>Humans<br/>Mutation--genetics<br/>Protein Serine-Threonine Kinases<br/>Protein Subunits<br/>RNA, Messenger--genetics<br/>Receptor, Transforming Growth Factor-beta Type II<br/>Receptors, Transforming Growth Factor beta--chemistry<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction--drug effects<br/>Transforming Growth Factor beta--metabolism<br/>Tumor Cells, Cultured